Back to company

ACUPHARMA ApS: Financial statements 2018

CVR: 10072956

ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,724,257 and a net result of DKK 5,216 compared with DKK 80,359 the year before. That is an increase of 13.9% compared with the year before. Equity amounted to DKK 153,966. The solvency ratio was 4.7%.

Gross Profit
1,724,257 kr.
Profit/Loss
5,216 kr.
Equity
153,966 kr.
Total Assets
3,258,412 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-1.7 mio.5 t.154 t.-
2017-1.5 mio.80 t.149 t.-
2016-1.1 mio.10568 t.-
2015-322 t.-360 t.68 t.-
2014-1.4 mio.551 t.773 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ACUPHARMA ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

ACUPHARMA ApS: The 2017 annual report is outMar 11, 2018

ACUPHARMA ApS has published its annual report for 2017. Gross profit came to DKK 1,513,402, and the net result was DKK 80,359.

About ACUPHARMA ApS

ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees. In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity amounted to DKK -109,301.